A new research perspective was published in Oncotarget’s Volume 15 on January 16, 2024, entitled, “Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma.”
Nova Cannabis Q1 Revenue Falls 2% Sequentially
Nova Announces First Quarter 2023 Results First quarter revenue growth of 20.8%; gross margin improvement to 21.4%; and Adjusted EBITDA growth of 127% to $3.2